Kim and Huang [194] have reported that a synthetic peptide mimicking the EGFR Y845 site (EEEEpYFELV) can be successfully delivered into lung cancer cells, H460, and to the tumor in a xenograft mouse model, by which biochemical (e.g., STAT5 phosphorylation) as well as cell biological functions (e.g., tumor growth) of cancer are effectively blocked. This evidence concerns the gene EGFR and cancer.